Finance

Lists
FAGR:EBR
Fagron NV
€22,75
+1,11%
(+0,25) 1D
15 Okt., 17:35:27 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for FAGR...
Open
€22,55
High
€22,90
Low
€22,40
Mkt. cap
1,66 mjd
Avg. vol.
98,84 k
Volume
133,91 k
Dividend
1,23%
Quarterly dividend
€0,07
Ex-dividend date
18 Mei 2026
P/E ratio
18,20
52-wk high
€25,30
52-wk low
€20,00
EPS
€1,25
Shares outstanding
73,82 m
No. of employees
5 k
Open
€22,55
High
€22,90
Low
€22,40
Mkt. cap
1,66 mjd
Avg. vol.
98,84 k
Volume
133,91 k
Dividend
1,23%
Quarterly dividend
€0,07
Ex-dividend date
18 Mei 2026
P/E ratio
18,20
52-wk high
€25,30
52-wk low
€20,00
EPS
€1,25
Shares outstanding
73,82 m
No. of employees
5 k
News stories
From web sources and news partners
Profile
Fagron NV is a publicly traded multinational group of companies governed by Belgian law. Its registered office is located in Waregem, Belgium, and its headquarters is located at Rotterdam, Netherlands. Founded as Arseus NV, it was formerly the Professional Health Division of Omega Pharma, and became an independent entity via an IPO on October 5, 2007 and has been listed on Euronext Brussels and Euronext Amsterdam since then. Its share is included in the BEL MID-index and the Amsterdam Small Cap Index. The head office of Fagron is located in Rotterdam. Wikipedia
About Fagron NV
CEORafael Padilla
Employees4,88 k
Founded1990
Headquarters-
SectorHealth care provider
Websitefagron.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
238,02 m
238,02 m
276,24 m
276,24 m
Cost of goods sold
130,74 m
130,74 m
155,20 m
155,20 m
Cost of revenue
130,74 m
130,74 m
155,20 m
155,20 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
58,85 m
58,85 m
67,70 m
67,70 m
Operating expense
71,39 m
71,39 m
83,13 m
83,13 m
Total operating expenses
202,14 m
202,14 m
238,34 m
238,34 m
Operating income
35,88 m
35,88 m
37,90 m
37,90 m
Other non operating income
-2,10 m
-2,10 m
-1,70 m
-1,70 m
EBT including unusual items
29,27 m
29,27 m
29,00 m
29,00 m
EBT excluding unusual items
28,65 m
28,65 m
29,00 m
29,00 m
Income tax expense
6,40 m
6,40 m
5,73 m
5,73 m
Effective tax rate
21,86%
21,86%
19,77%
19,77%
Other operating expenses
810,00 k
810,00 k
784,50 k
784,50 k
Net income
22,73 m
22,73 m
23,14 m
23,14 m
Net profit margin
9,55%
9,55%
8,38%
8,38%
Earnings per share
-
-
-
-
Interest and investment income
1,16 m
1,16 m
1,15 m
1,15 m
Interest expense
-5,28 m
-5,28 m
-8,03 m
-8,03 m
Net interest expenses
-4,12 m
-4,12 m
-6,88 m
-6,88 m
Depreciation and amortization charges
11,74 m
11,74 m
14,65 m
14,65 m
EBITDA
40,01 m
40,01 m
47,29 m
47,29 m
Gain or loss from assets sale
-140,50 k
-140,50 k
-119,50 k
-119,50 k
AI content may include mistakes. Learn more
Google-programme